Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Fitbit (FIT) Stock Gains On Settlement Of Jawbone Lawsuit

Published 12/11/2017, 10:33 PM
Updated 07/09/2023, 06:31 AM

Shares of Fitbit, Inc. (NYSE:FIT) gained approximately 2.4% on Monday after the company announced a lawsuit settlement with AliphCom LLC (assignment for the benefit of creditors), the assignee for the former Jawbone.

Shares of Fitbit have declined 2.4% year to date, underperforming the 18.1% rally of the industry it belongs to.



Litigation Details

The two companies have been embroiled in a legal battle since May 2015, when Jawbone accused Fitbit of poaching employees and stealing critical proprietary information. Jawbone said in its complaint that Fitbit had hired five of its employees who brought over 350,000 confidential files, which included information on materials, sensors and details of cost structure and profits.

Fitbit’s reputation suffered because of the lawsuit. It would have also lost significant wealth had it not settled the lawsuit. At the start of this year, the company’s shares witnessed a significant decline because of the lawsuit.

On Friday, Fitbit and AliphCom came to a global settlement agreement, thus resolving the outstanding litigation between the parties for an undisclosed amount. The development was cheered by investors as for the first time since late January, the company’s shares closed above $7. In fact, its shares gained 3.9% in midday trading on Monday.

Bottom Line

Though Fitbit enjoys a leading position in the wearable space, the cut-throat competition in both the high- and low-end product ranges cannot be denied.

The recent settlement should help the company in regaining its lost reputation and also save it from incurring huge monetary losses.

Zacks Rank & Stocks to Consider

Fitbit has a Zacks Rank #3 (Hold).

Orbotech Ltd. (NASDAQ:ORBK) , Aehr Test Systems (NASDAQ:AEHR) and Keysight Technologies Inc. (NYSE:KEYS) are some of the better-ranked stocks in the same industry. While Orbotech sports a Zacks Rank #1 (Strong Buy), Aehr Test Systems and Keysight carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth for Orbotech, Aehr Test Systems and Keysight is projected to be 18.75%, 20% and 8.19%, respectively.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Click here for the 6 trades >>



Orbotech Ltd. (ORBK): Free Stock Analysis Report

Keysight Technologies Inc. (KEYS): Free Stock Analysis Report

Fitbit, Inc. (FIT): Free Stock Analysis Report

Aehr Test Systems (AEHR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.